..ELBIT IMAGING LTD ..Israel

Elbit Imaging Announces Court's Approval of the Arrangement
09:20 02.01.14

PR Newswire

TEL AVIV, Israel, January 2, 2014

TEL AVIV, Israel, January 2, 2014 /PRNewswire/ --

Elbit Imaging Ltd. (the "Company") (TASE, NASDAQ: EMITF) announced today, further to the Company's announcements on September 18, 2013 and on December 30, 2013 with respect to the adjusted plan of arrangement submitted to the Tel-Aviv Jaffa District Court (the "Court") in file No. 42576-02-13 (the "Arrangement"), that the Court, in a ruling issued today, approved the Arrangement. The consummation of the Arrangement is subject to customary conditions. The Court requested that the Company provide it with an update on the status thereof by February 4, 2014. The Company intends to diligently pursue the consummation of the Arrangement as set forth in the Court ruling.

As to the dispute between the Company and Bank Leumi Le Israel B.M. ("Bank Leumi") regarding the validity of certain pledges registered in its favor, the Court noted that it should be resolved separately and the status of Bank Leumi and the application of the Arrangement thereto, shall be determined according to the outcome of such proceedings.

About Elbit Imaging Ltd.

Elbit Imaging Ltd. operates in the following principal fields of business: (i) Commercial and Entertainment Centers - Initiation, construction and sale of shopping and entertainment centers and other mixed-use real property projects, predominantly in the retail sector, located in Central and Eastern Europe and in India, primarily through its subsidiary Plaza Centers N.V. In certain circumstances and depending on market conditions, the Company operate and manage commercial and entertainment centers prior to their sale; (ii) Hotels - Hotel operation and management; (iii) Medical Industries - (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine; (iv) Residential Projects - Initiation, construction and sale of residential projects and other mixed-use real property projects, predominately residential, located primarily in India; and (v) Fashion Apparel - Distribution and marketing of fashion apparel and accessories in Israel.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Any forward-looking statements in our releases include statements regarding the intent, belief or current expectations of Elbit Imaging Ltd. and our management about our business, financial condition, results of operations, and its relationship with its employees and the condition of our properties. Words such as "believe," "would," "expect," "intend," "estimate" and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors including, without limitation, that challenges by third parties or other events outside the control of the Company could delay the implementation of the Arrangement and result in its termination, that the Company will be unable to close the agreement with Bank Hapoalim, the risk that the Company will enter liquidation proceedings, and the factors set forth in our filings with the Securities and Exchange Commission including, without limitation, Item 3.D of our annual report on Form 20-F for the fiscal year ended December 31, 2012, under the caption "Risk Factors." Any forward-looking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forward-looking statements do not purport to be predictions of future events or circumstances, and therefore, there can be no assurance that any forward-looking statement contained our releases will prove to be accurate. We undertake no obligation to update or revise any forward-looking statements.

For Further Information:

Company Contact:

Shimon Yitzhaki

Chairman of the Board of Directors

Tel: +972-3-608-6048

shimony@elbitimaging.com

Investor Contact:

Mor Dagan

Investor Relations

Tel: +972-3-516-7620

mor@km-ir.co.il

SOURCE Elbit Imaging Ltd.


Quelle: PR Newswire  

principal fields of business: (i) Commercial and Entertainment Centers - Initiation, construction and sale of shopping and entertainment centers and other mixed-use real property projects, predominantly in the retail sector, located in Central and Eastern Europe and in India, primarily through its subsidiary Plaza Centers N.V. In certain circumstances and depending on market conditions, the Company operate and manage commercial and entertainment centers prior to their sale; (ii) Hotels - Hotel operation and management; (iii) Medical Industries - (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine; (iv) Residential Projects - Initiation, construction and sale of residential projects and other mixed-use real property projects, predominately residential, located primarily in India; and (v) Fashion Apparel - Distribution and marketing of fashion apparel and accessories in Israel.
SOURCE Elbit Imaging Ltd.


Quelle: PR Newswire
 

in our releases include statements regarding the intent, belief or current expectations of Elbit Imaging Ltd. and our management about our business, financial condition, results of operations, and its relationship with its employees and the condition of our properties. Words such as "believe," "would," "expect," "intend," "estimate" and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors including, without limitation, that challenges by third parties or other events outside the control of the Company could delay the implementation of the Arrangement and result in its termination, that the Company will be unable to close the agreement with Bank Hapoalim, the risk that the Company will enter liquidation proceedings, and the factors set forth in our filings with the Securities and Exchange Commission including, without limitation, Item 3.D of our annual report on Form 20-F for the fiscal year ended December 31, 2012, under the caption "Risk Factors." Any forward-looking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forward-looking statements do not purport to be predictions of future events or circumstances, and therefore, there can be no assurance that any forward-looking statement contained our releases will prove to be accurate. We undertake no obligation to update or revise any forward-looking statements.
SOURCE Elbit Imaging Ltd.


Quelle: PR Newswire
 

Elbit Imaging Defers Adoption of Compensation Policy
15:05 12.01.14

PR Newswire

TEL AVIV, Israel, January 12, 2014

TEL AVIV, Israel, January 12, 2014 /PRNewswire/ --

Elbit Imaging Ltd. (the "Company") (TASE, NASDAQ: EMITF) announced today that it has decided to defer the adoption of a compensation policy for the Company's directors and officers pursuant to the Israeli Companies Law. As previously announced, on January 1, 2014, the Tel-Aviv Jaffa District Court approved the Company's adjusted plan of arrangement for a restructuring of the Company's unsecured financial debt, among other things. The Company expects that following the consummation of the restructuring, the shareholders of the Company will elect a new board of directors, which will formulate the Company's business strategy, including a compensation policy for the Company's officers and directors.  

About Elbit Imaging Ltd.

Elbit Imaging Ltd. operates in the following principal fields of business: (i) Commercial and Entertainment Centers - Initiation, construction and sale of shopping and entertainment centers and other mixed-use real property projects, predominantly in the retail sector, located in Central and Eastern Europe and in India, primarily through its subsidiary Plaza Centers N.V. In certain circumstances and depending on market conditions, the Company operate and manage commercial and entertainment centers prior to their sale; (ii) Hotels - Hotel operation and management; (iii) Medical Industries - (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine; (iv) Residential Projects - Initiation, construction and sale of residential projects and other mixed-use real property projects, predominately residential, located primarily in India; and (v) Fashion Apparel - Distribution and marketing of fashion apparel and accessories in Israel.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Any forward-looking statements in our releases include statements regarding the intent, belief or current expectations of Elbit Imaging Ltd. and our management about our business, financial condition, results of operations, and its relationship with its employees and the condition of our properties. Words such as "believe," "would," "expect," "intend," "estimate" and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors including, without limitation, that challenges by third parties or other events outside the control of the Company could delay the implementation of the Arrangement and result in its termination, that the Company will be unable to close the agreement with Bank Hapoalim, the risk that the Company will enter liquidation proceedings, and the factors set forth in our filings with the Securities and Exchange Commission including, without limitation, Item 3.D of our annual report on Form 20-F for the fiscal year ended December 31, 2012, under the caption "Risk Factors." Any forward-looking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forward-looking statements do not purport to be predictions of future events or circumstances, and therefore, there can be no assurance that any forward-looking statement contained our releases will prove to be accurate. We undertake no obligation to update or revise any forward-looking statements.



For Further Information:

Company Contact:

Shimon Yitzhaki

Chairman of the Board of Directors

Tel: +972-3-608-6048

shimony@elbitimaging.com  

Investor Contact:

Mor Dagan

Investor Relations

Tel: +972-3-516-7620

mor@km-ir.co.il


SOURCE Elbit Imaging Ltd.


Quelle: PR Newswire  

Datum Erster Hoch Tief Schluss     Stücke Volumen
  10.01.14      1,08      1,08§1,0019 1,07 $ 17.597 18.553

GrB  

Litigation Reform Act of 1995

Any forward-looking statements in our releases include statements regarding the intent, belief or current expectations of Elbit Imaging Ltd. and our management about our business, financial condition, results of operations, and its relationship with its employees and the condition of our properties. Words such as "believe," "would," "expect," "intend," "estimate" and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors including, without limitation, that challenges by third parties or other events outside the control of the Company could delay the implementation of the Arrangement and result in its termination, that the Company will be unable to close the agreement with Bank Hapoalim, the risk that the Company will enter liquidation proceedings, and the factors set forth in our filings with the Securities and Exchange Commission including, without limitation, Item 3.D of our annual report on Form 20-F for the fiscal year ended December 31, 2012, under the caption "Risk Factors." Any forward-looking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forward-looking statements do not purport to be predictions of future events or circumstances, and therefore, there can be no assurance that any forward-looking statement contained our releases will prove to be accurate. We undertake no obligation to update or revise any forward-looking statements.



For Further Information:

Company Contact:

Shimon Yitzhaki

Chairman of the Board of Directors

Tel: +972-3-608-6048

shimony@elbitimaging.com  

Investor Contact:

Mor Dagan

Investor Relations

Tel: +972-3-516-7620

mor@km-ir.co.il


SOURCE Elbit Imaging Ltd.


Quelle: PR Newswire  

Preis pro share 1,02 $ Schleife 1.000 spread 3,03% buran und MfG und tau  

Zeit     Kurs Stück
  16:04:35§0,737 € 1.000
___________________
GRATULATION  

Zeit


      Kurs               Stück                    §
  20:12:44§1,04 $
     2.700                    §
  20:10:16§1,04 $
       300                    §
  19:47:58§1,0497 $
       100                    §
  19:18:35§1,02 $
       200                    §
  19:17:13§1,0003 $
       800                    §
  18:15:09§1,0599 $
       239                    §
  17:45:03§1,05 $
       100                    §
  17:44:26§1,0597 $
       200                    §
  17:41:27§1,06 $
       500                    §
  17:39:13§1,04 $
       100                    §
  17:38:45§1,03 $
       300                    §
  17:38:44§1,03 $
       200                    §
  17:38:39§1,03 $
       500                    §
  17:38:33§1,02 $
       100                    §
  17:38:16§1,02 $
       200                    §
  17:38:09§1,01 $
     1.600                    §
  17:38:05§1,01 $
       100                    §
  17:13:24§1,0096 $
       425                    §
  17:06:12§1,00 $
       100                    §
  16:55:46§1,01 $
       100                    §
  16:43:35§1,0103 $
       300                    §
  16:43:35§1,05 $
       400                    §
  16:42:04§1,049 $
       112                    §
  16:39:05§1,02 $
     4.200                    §
  16:35:56§1,06 $
       200                    §
  16:29:19§1,01 $
       600                    §
  16:26:21§1,02 $
       200                    §
  16:23:07§1,00 $
       186                    §
  16:23:05§1,00 $
       200                    §
  16:22:46§1,00 $
       114                    §
  15:33:03§1,01 $
     1.100                    §
  15:30:00§1,03 $
100
GrB  

Datum Erster Hoch Tief Schluss     Stücke Volumen
  17.01.14      1,13      1,13§1,06 1,06 $ 9.657 10.235

GrB  

Elbit Imaging Announces Noteholder's Filing of an Appeal with Regards to Approval of the Arrangment
14:20 02.02.14

PR Newswire

TEL AVIV, Israel, February 2, 2014

TEL AVIV, Israel, February 2, 2014 /PRNewswire/ --

Elbit Imaging Ltd. (the "Company") (TASE, NASDAQ: EMITF) announced today, further to the Company's announcement dated January 2, 2014 with respect to the approval of the adjusted plan of arrangement submitted to the Tel-Aviv Jaffa District Court (the "Court") in file No. 42576-02-13 (the "Arrangement") by the Court, that a holder of Series B Notes (the "Holder"), which filed a purported class action lawsuit against the Company with the Court on April 11, 2013 as announced by the Company on April 15, 2013 ("Purported Class Action"), filed with the Israel Supreme Court an appeal arguing that the Court erred in approving the Arrangement. It is noted that such appellant holds approximately 0.1% of the total unsecured debt of the Company. The Company rejects such argument and intends to defend the case vigorously and is continuing with pursuing the consummation of the Arrangement and the completion thereof.

About Elbit Imaging Ltd.

Elbit Imaging Ltd. operates in the following principal fields of business: (i) Commercial and Entertainment Centers - Initiation, construction and sale of shopping and entertainment centers and other mixed-use real property projects, predominantly in the retail sector, located in Central and Eastern Europe and in India, primarily through its subsidiary Plaza Centers N.V. In certain circumstances and depending on market conditions, the Company operates and manages commercial and entertainment centers prior to their sale; (ii) Hotels - Hotel operation and management; (iii) Medical Industries - (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine; (iv) Residential Projects - Initiation, construction and sale of residential projects and other mixed-use real property projects, predominately residential, located primarily in India; and (v) Fashion Apparel - Distribution and marketing of fashion apparel and accessories in Israel.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Any forward-looking statements in our releases include statements regarding the intent, belief or current expectations of Elbit Imaging Ltd. and our management about our business, financial condition, results of operations, and its relationship with its employees and the condition of our properties. Words such as "believe," "would," "expect," "intend," "estimate" and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors including, without limitation, that challenges by third parties or other events outside the control of the Company could delay the implementation of the Arrangement and result in its termination, that the Company will be unable to close the agreement with Bank Hapoalim, the risk that the Company will enter liquidation proceedings, and the factors set forth in our filings with the Securities and Exchange Commission including, without limitation, Item 3.D of our annual report on Form 20-F for the fiscal year ended December 31, 2012, under the caption "Risk Factors." Any forward-looking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forward-looking statements do not purport to be predictions of future events or circumstances, and therefore, there can be no assurance that any forward-looking statement contained our releases will prove to be accurate. We undertake no obligation to update or revise any forward-looking statements.

For Further Information:

Company Contact:

Shimon Yitzhaki

Chairman of the Board of Directors

Tel: +972-3-608-6048

shimony@elbitimaging.com

Investor Contact:

Mor Dagan

Investor Relations

Tel: +972-3-516-7620

mor@km-ir.co.il

SOURCE Elbit Imaging Ltd.


Quelle: PR Newswire  

Elbit Imaging Announces the Results of the Company's Unsecured Financial Creditors Meeting Approving Postponement of the Creating and Registering of the Collaterals Securing the New Notes
15:10 10.02.14

PR Newswire

TEL AVIV, Israel, February 10, 2014

TEL AVIV, Israel, February 10, 2014 /PRNewswire/ --

Elbit Imaging Ltd. (the "Company") (TASE, NASDAQ: EMITF) announced today, further to the Company's announcements on September 18, 2013 and January 2, 2014 (the "Previous Announcement"), the results of the meeting of the Company's unsecured financial creditors (the "Meeting") that voted on the postponement  of the creating and registering of the collaterals securing the new notes ("New Notes") which shall be issued under the terms of the plan of arrangement between the Company and its unsecured financial creditors (the "Arrangement") by 45 business days following the closing of the Arrangement. Accordingly the creating and registering shall be deemed an undertaking of the Company (rather than a condition precedent to the closing of the Arrangement), the failure to satisfy thereof, shall render the holders of the New Notes the right to demand early repayment of any and all amounts due under the New Notes (the "Resolution").

At the Meeting, unsecured financial creditors holding approximately 99.8% of the aggregate voting power participating in the Meeting voted in favor of the Resolution.

The closing of the Arrangement remains subject to other conditions precedent, as described in the Previous Announcement, which the Company is pursuing with the objective to execute the same as early as possible.

Following the request of the trustees of the noteholders, the Company reported at the Meeting that the Board of Directors of the Company has authorized it to enter into negotiations and subsequently to enter into a non-binding letter of intent for the pursuit of a certain investment in the share capital of its subsidiary that is participating in a tender for a project in Greece.

About Elbit Imaging Ltd.

Elbit Imaging Ltd. operates in the following principal fields of business: (i) Commercial and Entertainment Centers - Initiation, construction and sale of shopping and entertainment centers and other mixed-use real property projects, predominantly in the retail sector, located in Central and Eastern Europe and in India, primarily through its subsidiary Plaza Centers N.V. In certain circumstances and depending on market conditions, the Company operate and manage commercial and entertainment centers prior to their sale; (ii) Hotels - Hotel operation and management; (iii) Medical Industries - (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine; (iv) Residential Projects - Initiation, construction and sale of residential projects and other mixed-use real property projects, predominately residential, located primarily in India; and (v) Fashion Apparel - Distribution and marketing of fashion apparel and accessories in Israel.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Any forward-looking statements in our releases include statements regarding the intent, belief or current expectations of Elbit Imaging Ltd. and our management about our business, financial condition, results of operations, and its relationship with its employees and the condition of our properties. Words such as "believe," "would," "expect," "intend," "estimate" and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors including, without limitation, that the Tel-Aviv District Court may reject the Postponement, that challenges by third parties or other events outside the control of the Company could delay the implementation of the Arrangement and result in its termination, that the Company will be unable to close the agreement with Bank Hapoalim, the risk that the Company will enter liquidation proceedings, and the factors set forth in our filings with the Securities and Exchange Commission including, without limitation, Item 3.D of our annual report on Form 20-F for the fiscal year ended December 31, 2012, under the caption "Risk Factors." Any forward-looking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forward-looking statements do not purport to be predictions of future events or circumstances, and therefore, there can be no assurance that any forward-looking statement contained our releases will prove to be accurate. We undertake no obligation to update or revise any forward-looking statements.

For Further Information:

Company Contact:    

Shimon Yitzhaki    

Chairman of the Board of Directors    

Tel: +972-3-608-6048    

shimony@elbitimaging.com      

SOURCE Elbit Imaging Ltd.


Quelle: PR Newswire  

Elbit Imaging Announces Timetable and Other Material Information Regarding the Restructuring
13:10 18.02.14

PR Newswire

TEL AVIV, Israel, February 18, 2014

TEL AVIV, Israel, February 18, 2014 /PRNewswire/ --

Elbit Imaging Ltd. (the "Company") (TASE, NASDAQ: EMITF) announced today that, further to the Company's announcements on September 18, 2013 and January 2, 2014 (the "Previous Announcements") with respect to the ruling given by the District Court of Tel Aviv-Jaffa (the "Court") in File No. 42576-02-13 (the "Court Ruling"), which approved the restructuring plan between the Company and the Company's unsecured financial creditors (the "Restructuring"), that on February 16, 2014 the Tel Aviv Stock Exchange approved the Restructuring and the listing of 509,713,459 ordinary shares of the Company with no par value (the "Issued Shares") and the Company's NIS 448,000,000 par value Series H Notes as well as the Company's NIS 218,000,000 par value Series I Notes (the "New Notes"), such approval representing fulfillment of the conditions precedent as set in Section 7 to the Restructuring plan.

The timetable for performance of the Restructuring is as follows:

The Closing of the Restructuring will be February 20, 2014 (the "Closing Date").
The record date for the Restructuring will be February 20, 2014 (the "Record Date").
The last trade date for the Company's Series A to G and 1 Notes will be February 17, 2014.
Certain material terms of the Restructuring follow:

Cancellation of the existing notes

In the framework of the Restructuring, all of the Company's Series A to G and 1 Notes as well as the notes representing the unpaid portion of the principal in the Series A and Series B Notes (numbered "Elbthad A HS 2/13" and "Elbthad B HS 2/13", respectively), will be cancelled and delisted including the interest payments in respect of A Notes and B Notes which had not been paid as of February 20, 2013, interest payment in respect of C Notes which had not been paid as of March 1, 2013, and including interest payment in respect of F Notes which had not been paid on April 1, 2013 (jointly: the "Existing Notes").

Allotment of the issued shares and the new notes

On the Closing Date, the Company will allot and deposit with the TASE Clearing House the Issued Shares and the New Notes to the Company's unsecured financial creditors (whomever will be holding the Existing Notes on the Restructuring Record Date as well as Bank Leumi Le-Israel Ltd.). The Issued Shares and New Notes are expected to be distributed to such unsecured financial creditors on February 23, 2014.

It is clarified that the notes held by the Company's subsidiary will be cancelled with no consideration given.

First payment of interest in respect of the Series H Notes

The record date for the first payment of interest in respect of the Series H Notes will be February 23, 2014. The date of the aforesaid first payment of interest will be March 9, 2014.

Share issuance to Bank Hapoalim Ltd.

In accordance with the Court Ruling, on the Closing Date the Company will allot Bank Hapoalim Ltd. ("Bank Hapoalim") and deposit with the TASE Clearing House 16,594,036 ordinary shares of the Company with no par value, pursuant to an agreement between the Company and Bank Hapoalim as detailed in the Company's announcement on November 14, 2013.

About Elbit Imaging Ltd.

Elbit Imaging Ltd. operates in the following principal fields of business: (i) Commercial and Entertainment Centers - Initiation, construction and sale of shopping and entertainment centers and other mixed-use real property projects, predominantly in the retail sector, located in Central and Eastern Europe and in India, primarily through its subsidiary Plaza Centers N.V. In certain circumstances and depending on market conditions, the Company operate and manage commercial and entertainment centers prior to their sale; (ii) Hotels - Hotel operation and management; (iii) Medical Industries - (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine; (iv) Residential Projects - Initiation, construction and sale of residential projects and other mixed-use real property projects, predominately residential, located primarily in India; and (v) Fashion Apparel - Distribution and marketing of fashion apparel and accessories in Israel.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Any forward-looking statements in our releases include statements regarding the intent, belief or current expectations of Elbit Imaging Ltd. and our management about our business, financial condition, results of operations, and its relationship with its employees and the condition of our properties. Words such as "believe," "would," "expect," "intend," "estimate" and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors including, without limitation, that challenges by third parties or other events outside the control of the Company could delay the implementation of the Restructuring and result in its termination, that  the Company will be unable to close the agreement with Bank Hapoalim, the risk that the Company will be unable to close the grant of the collaterals to secure the New Notes pursuant to its undertaking, and the factors set forth in our filings with the Securities and Exchange Commission including, without limitation, Item 3.D of our annual report on Form 20-F for the fiscal year ended December 31, 2012, under the caption "Risk Factors." Any forward-looking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forward-looking statements do not purport to be predictions of future events or circumstances, and therefore, there can be no assurance that any forward-looking statement contained our releases will prove to be accurate. We undertake no obligation to update or revise any forward-looking statements.

For Further Information:

Company Contact:    

Shimon Yitzhaki    

Chairman of the Board of Directors    

Tel: +972-3-608-6048    

shimony@elbitimaging.com      

SOURCE Elbit Imaging Ltd.


Quelle: PR Newswire  

Distribution of Issued Shares and New Notes
18:25 18.02.14

PR Newswire

TEL AVIV, Israel, February 18, 2014

TEL AVIV, Israel, February 18, 2014 /PRNewswire/ --

Elbit Imaging Ltd. (the "Company") (TASE, NASDAQ: EMITF) announced today that, further to the Company's announcements dated February 18, 2014, that the Issued Shares and New Notes are expected to be distributed to such unsecured financial creditors on February 21, 2014 (rather than on February 23, 2014 as stated in the Company's previous announcement).

About Elbit Imaging Ltd.

Elbit Imaging Ltd. operates in the following principal fields of business: (i) Commercial and Entertainment Centers - Initiation, construction and sale of shopping and entertainment centers and other mixed-use real property projects, predominantly in the retail sector, located in Central and Eastern Europe and in India, primarily through its subsidiary Plaza Centers N.V. In certain circumstances and depending on market conditions, the Company operate and manage commercial and entertainment centers prior to their sale; (ii) Hotels - Hotel operation and management; (iii) Medical Industries - (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine; (iv) Residential Projects - Initiation, construction and sale of residential projects and other mixed-use real property projects, predominately residential, located primarily in India; and (v) Fashion Apparel - Distribution and marketing of fashion apparel and accessories in Israel.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Any forward-looking statements in our releases include statements regarding the intent, belief or current expectations of Elbit Imaging Ltd. and our management about our business, financial condition, results of operations, and its relationship with its employees and the condition of our properties. Words such as "believe," "would," "expect," "intend," "estimate" and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors including, without limitation, that challenges by third parties or other events outside the control of the Company could delay the implementation of the Restructuring and result in its termination, that  the Company will be unable to close the agreement with Bank Hapoalim, the risk that the Company will be unable to close the grant of the collaterals to secure the New Notes pursuant to its undertaking, and the factors set forth in our filings with the Securities and Exchange Commission including, without limitation, Item 3.D of our annual report on Form 20-F for the fiscal year ended December 31, 2012, under the caption "Risk Factors." Any forward-looking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forward-looking statements do not purport to be predictions of future events or circumstances, and therefore, there can be no assurance that any forward-looking statement contained our releases will prove to be accurate. We undertake no obligation to update or revise any forward-looking statements.



For Further Information:

Company Contact:    

Shimon Yitzhaki    

Chairman of the Board of Directors    

Tel: +972-3-608-6048    

shimony@elbitimaging.com    



SOURCE Elbit Imaging Ltd.


Quelle: PR Newswire  

Elbit Imaging Ltd. Consummates Debt Restructuring and Calls Extraordinary General Meeting of Shareholders
18:45 20.02.14

PR Newswire

TEL AVIV, Israel, February 20, 2014

TEL AVIV, Israel, February 20, 2014 /PRNewswire/ --

Elbit Imaging Ltd. (NASDAQ: EMITF) (the "Company") announced today that, further to its announcement on January 2, 2014 regarding the Tel-Aviv Jaffa District Court's (the "Court") approval of the plan of arrangement with its unsecured financial creditors (respectively, the "Arrangement" and "Court Ruling"), the closing of the Arrangement (the "Closing") took place today (February 20, 2014). As part of the Arrangement, 509,713,459 ordinary shares were issued to the Company's unsecured financial creditors, out of which 9,090,122 ordinary shares were issued at the Closing and deposited in trust for the benefit of Bank Leumi Le Israel B.M. ("Bank Leumi"), due to the ongoing dispute between the Company and Bank Leumi regarding the validity of certain pledges registered in Bank Leumi's favor.

Immediately following the Closing, as contemplated by the Arrangement, (i) the closing of the refinancing agreement ("Refinancing Agreement") between the Company and Bank Hapoalim B.M ("Bank Hapoalim") as described in the Company's announcements on November 14, 2013, November 26, 2013 and December 30, 2013, was held, at which 16,594,036 ordinary shares were issued to Bank Hapoalim, and (ii) the warrant to purchase ordinary shares of the Company issued to Eastgate Property LLC, as described in the Company's announcement on September 25, 2011 and amended as described in the Company's announcement on April 6, 2012 (the "Warrant"), was exercised for 1,924,215 ordinary shares and terminated.

Following the Closing, the issued and outstanding share capital of the Company consists of 553,134,519 ordinary shares and the total corporate level debt (excluding the disputed debt to Bank Leumi) amounted to NIS835 million ($237 million) and consists of the following:

NIS 448 million (approximately $127 million) aggregate principal amount of Series H notes and NIS 218 million (approximately $62 million) aggregate principal amount of Series I notes (out of which approximately NIS 8 million principal amount of Series H notes and approximately NIS 3.9 million principal amount of Series I notes were issued at the Closing and deposited in trust for the benefit of Bank Leumi due to the abovementioned dispute); and

Approximately $48 million (approximately NIS 169 million) principal amount of secured debt to Bank Hapoalim under the Refinancing Agreement.

As described in the Company's announcement dated February 10, 2014, the creation and registration of collateral securing the Series H and Series I notes is scheduled to be completed within 45 business days following the Closing.

Extraordinary General Meeting

Furthermore, in accordance with the Court Ruling and a subsequent ruling issued by the Court on February 12, 2014 (the "Subsequent Ruling"), the Company has scheduled a general meeting of shareholders to take place on Thursday, March 13, 2014 at 11:00 a.m. (Israel time), at the offices of the Company, located at 5 Kinneret Street, 32nd Floor, Bnei-Brak, Israel (the "Meeting"), telephone: +972-3-608-6078. The record date for the Meeting is expected to be March 4, 2014.

The agenda of the Meeting is to elect up to seven members of the Company's Board of Directors, in place of the current directors who are not external directors. The Company's external directors, Mr. Zvi Tropp and Mrs. Elina Frenkel Ronen, will continue to serve their respective three-year terms.

The election of each nominee requires the approval of a simple majority of the shares voted on the matter. If more than seven individuals are duly nominated and approved, the seven nominees receiving the highest number of votes will be elected.

In accordance with the Subsequent Ruling, proxy statements describing the proposal on the agenda and proxy cards for use by shareholders that cannot attend the meeting in person will not be mailed to shareholders. Instead, they will be filed electronically on the Securities and Exchange Commission's EDGAR website on Form 6-K on or about February 27, 2014. Each shareholder who is unable to attend the meeting in person will be required to print, complete, date and sign the proxy card and deliver it to the Company as described in the proxy statement. Any shareholder who holds ordinary shares in "street name" will be required to contact the broker and receive a proxy to vote the shares on behalf of the broker as well as a statement from such broker that it did not vote such shares, and return such proxy and statement along with their proxy card to the Company as described in the proxy statement.  The voting of shares held through a member of the Tel Aviv Stock Exchange Clearinghouse will follow customary Israeli procedures.

Shareholders holding at least one percent (1%) of the Company's voting power on the record date for the Meeting (i.e., 5,531,345 ordinary shares) who wish to nominate directors for election at the Meeting are encouraged to do so by notifying the Board of Directors via hand delivery or registered mail (at 5 Kinneret Street, Bnei-Brak, Israel) or facsimile (at +972-3-608-6050), no later than February 27, 2014 at 11:00 a.m. (Israel time). Any such nomination must include a brief biography of the nominee, the consent of the nominee to serve, a signed declaration of the nominee that complies with Section 224B of the Israeli Companies Law and indicates whether or not (and if not, the reasons why) the nominee would qualify as an independent director under the Companies Law and the Listing Rules of the NASDAQ Stock Market, the name and contact information of the nominating shareholder(s) and evidence of the requisite share ownership in the Company. The required forms may be downloaded from the Company's website at:  http://www.elbitimaging.com under: "Investor Relations - Company Presentation".

Miscellaneous

Any claims for the reimbursement of expenses incurred by unsecured financial creditors in connection with the Arrangement pursuant to Section 18 thereof, should be brought to the Company's attention no later than March 6, 2014 at 5:00 p.m. (Israel time), in accordance with the procedures described on  the Company's website at:  http://www.elbitimaging.com,  under: "Investor Relations - Company Presentation - Debt Claims".

About Elbit Imaging Ltd.

Elbit Imaging Ltd. operates in the following principal fields of business: (i) Commercial and Entertainment Centers - Initiation, construction and sale of shopping and entertainment centers and other mixed-use real property projects, predominantly in the retail sector, located in Central and Eastern Europe and in India, primarily through its subsidiary Plaza Centers N.V. In certain circumstances and depending on market conditions, the Company operate and manage commercial and entertainment centers prior to their sale; (ii) Hotels - Hotel operation and management; (iii) Medical Industries - (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine; (iv) Residential Projects - Initiation, construction and sale of residential projects and other mixed-use real property projects, predominately residential, located primarily in India; and (v) Fashion Apparel - Distribution and marketing of fashion apparel and accessories in Israel.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Any forward-looking statements in our releases include statements regarding the intent, belief or current expectations of Elbit Imaging Ltd. and our management about our business, financial condition, results of operations, and its relationship with its employees and the condition of our properties. Words such as "believe," "would," "expect," "intend," "estimate" and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors including, without limitation, the factors set forth in our filings with the Securities and Exchange Commission including, without limitation, Item 3.D of our annual report on Form 20-F for the fiscal year ended December 31, 2012, under the caption "Risk Factors." Any forward-looking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forward-looking statements do not purport to be predictions of future events or circumstances, and therefore, there can be no assurance that any forward-looking statement contained our releases will prove to be accurate. We undertake no obligation to update or revise any forward-looking statements.



For Further Information:

Company Contact:    

Shimon Yitzhaki    

Chairman of the Board of Directors    

Tel: +972-3-608-6048    

shimony@elbitimaging.com    





SOURCE Elbit Imaging Ltd.


Quelle: PR Newswire  

Elbit Imaging Ltd. Announces Recogniton of Gain from Debt Restructuring and Compliance with NASDAQ Listing Rules
09:00 24.02.14

PR Newswire

TEL AVIV, Israel, February 24, 2014

TEL AVIV, Israel, February 24, 2014 /PRNewswire/ --

Elbit Imaging Ltd. (NASDAQ: EMITF) (the "Company") announced today that as a result of the closing of the plan of arrangement among the Company and its unsecured financial creditors (the "Debt Restructuring") on February 20, 2014, the Company will recognize gain in the first quarter of 2014 in the total amount of approximately NIS 1.6 billion (approximately US$ 457 million). Furthermore, as a result of the Debt Restructuring, the Company's shareholders' equity will increase in the total amount of approximately NIS 1.9 billion (approximately US$ 544 million) (the "Shareholders Equity Increase").

Compliance with NASDAQ Listing Rules

Further to the Company's announcement on December 5, 2013 that it has received notice from the Listing Qualifications Department of The NASDAQ Stock Market LLC ("Nasdaq") that the Company has ceased to comply with Nasdaq Listing Rule 5450(b)(1)(A) requiring companies listed on the Nasdaq Global Select Market to maintain a minimum of US$10,000,000 in shareholders' equity (the "Listing Rule"), the Company announced today that it has regained compliance with the Listing Rule, as a result of the closing of the Debt Restructuring and the Shareholders Equity Increase.

Nasdaq will continue to monitor the Company's ongoing compliance with the shareholders' equity requirement and, if at the time of its next periodic report the Company does not evidence compliance, then in such event, it may be subject to delisting.

About Elbit Imaging Ltd.

Elbit Imaging Ltd. operates in the following principal fields of business: (i) Commercial and Entertainment Centers - Initiation, construction and sale of shopping and entertainment centers and other mixed-use real property projects, predominantly in the retail sector, located in Central and Eastern Europe and in India, primarily through its subsidiary Plaza Centers N.V. In certain circumstances and depending on market conditions, the Company operate and manage commercial and entertainment centers prior to their sale; (ii) Hotels - Hotel operation and management; (iii) Medical Industries - (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine; (iv) Residential Projects - Initiation, construction and sale of residential projects and other mixed-use real property projects, predominately residential, located primarily in India; and (v) Fashion Apparel - Distribution and marketing of fashion apparel and accessories in Israel.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Any forward-looking statements in our releases include statements regarding the intent, belief or current expectations of Elbit Imaging Ltd. and our management about our business, financial condition, results of operations, and its relationship with its employees and the condition of our properties. Words such as "believe," "would," "expect," "intend," "estimate" and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors including, without limitation, the factors set forth in our filings with the Securities and Exchange Commission including, without limitation, Item 3.D of our annual report on Form 20-F for the fiscal year ended December 31, 2012, under the caption "Risk Factors." Any forward-looking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forward-looking statements do not purport to be predictions of future events or circumstances, and therefore, there can be no assurance that any forward-looking statement contained our releases will prove to be accurate. We undertake no obligation to update or revise any forward-looking statements.

For Further Information:

Company Contact:

Shimon Yitzhaki

Chairman of the Board of Directors

Tel: +972-3-608-6048

shimony@elbitimaging.com


SOURCE Elbit Imaging Ltd.


Quelle: PR Newswire  

Elbit Imaging Ltd. Announces Filing of Proxy Statement and Proxy Card for Extraordinary General Meeting
20:50 27.02.14

PR Newswire

TEL AVIV, Israel, February 27, 2014

TEL AVIV, Israel, February 27, 2014 /PRNewswire/ --

Elbit Imaging Ltd. (NASDAQ: EMITF) (the "Company") announced today that, further to its announcement on February 20, 2014 (the "Previous Announcement") regarding the extraordinary general meeting of shareholders scheduled to take place on Thursday, March 13, 2014 at 11:00 a.m. (Israel time), at the offices of the Company, located at 5 Kinneret Street, 32nd Floor, Bnei-Brak, Israel (the "Meeting"), that a proxy statement describing the agenda and the form of proxy card for use by shareholders that cannot attend the Meeting in person were filed electronically today on Form 6-K with the Securities and Exchange Commission (SEC)  and is available on the SEC's EDGAR website. The record date for the Meeting is March 4, 2014.

The agenda of the Meeting is to elect up to seven members of the Company's Board of Directors, in place of the current directors who are not external directors. The Company's external directors, Mr. Zvi Tropp and Mrs. Elina Frenkel Ronen, will continue to serve their respective three-year terms. The following eight individuals have been nominated by shareholders holding at least one percent (1%) of the Company's voting power: Alon Bachar, Eliezer Avraham Brender, Ron Hadassi, Shlomo Kelsi, Yoav Kfir, Boaz Lifschitz, Nadav Livni and Shlomo Nass (the "Nominees"). A brief biography of each Nominee is included in the proxy statement.

The election of each Nominee requires the approval of a simple majority of the shares voted on the matter. If more than seven Nominees are duly approved, the seven Nominees receiving the highest number of affirmative votes will be elected.

In accordance with the ruling issued by the Tel Aviv-Jaffa District Court on February 12, 2014 (the "Ruling") and as more fully discussed in the Previous Announcement, proxy statements describing the proposal on the agenda and proxy cards for use by shareholders that cannot attend the meeting in person will not be mailed to shareholders. Each shareholder who is unable to attend the meeting in person will be required to print, complete, date and sign the proxy card and deliver it to the Company as described in the proxy statement. Any shareholder who holds ordinary shares in "street name" will be required to contact the broker and receive a proxy to vote the shares on behalf of the broker as well as a statement from such broker that it did not vote such shares, and return such proxy and statement along with their proxy card to the Company as described in the proxy statement.  The voting of shares held through a member of the Tel Aviv Stock Exchange Clearinghouse will follow customary Israeli procedures.

About Elbit Imaging Ltd.

Elbit Imaging Ltd. operates in the following principal fields of business: (i) Commercial and Entertainment Centers - Initiation, construction and sale of shopping and entertainment centers and other mixed-use real property projects, predominantly in the retail sector, located in Central and Eastern Europe and in India, primarily through its subsidiary Plaza Centers N.V. In certain circumstances and depending on market conditions, the Company operate and manage commercial and entertainment centers prior to their sale; (ii) Hotels - Hotel operation and management; (iii) Medical Industries - (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine; (iv) Residential Projects - Initiation, construction and sale of residential projects and other mixed-use real property projects, predominately residential, located primarily in India; and (v) Fashion Apparel - Distribution and marketing of fashion apparel and accessories in Israel.



For Further Information:

Company Contact:

Shimon Yitzhaki

Chairman of the Board of Directors

Tel: +972-3-608-6048

shimony@elbitimaging.com

SOURCE Elbit Imaging Ltd.


Quelle: PR Newswire  

Elbit Imaging Announces Court Decision to Reject the Request on Behalf of the Trustees of Series B Notes for Liquidation
16:30 06.03.14

PR Newswire

TEL AVIV, Israel, March 6, 2014

TEL AVIV, Israel, March 6, 2014 /PRNewswire/ --

Elbit Imaging Ltd. ("EI" or the "Company") (TASE, NASDAQ: EMITF) announced today further to the Company's announcement dated April 4, 2014, May 8, 2013 and July 2, 2013 that that the Tel Aviv District Court rejected the liquidation request of the trustees of the Company's Series B Notes.

About Elbit Imaging Ltd.

Elbit Imaging Ltd. operates in the following principal fields of business: (i) Commercial and Entertainment Centers - Initiation, construction and sale of shopping and entertainment centers and other mixed-use real property projects, predominantly in the retail sector, located in Central and Eastern Europe and in India, primarily through its subsidiary Plaza Centers N.V. In certain circumstances and depending on market conditions, the Company operate and manage commercial and entertainment centers prior to their sale; (ii) Hotels - Hotel operation and management; (iii) Medical Industries - (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine; (iv) Residential Projects - Initiation, construction and sale of residential projects and other mixed-use real property projects, predominately residential, located primarily in India; and (v) Fashion Apparel - Distribution and marketing of fashion apparel and accessories in Israel.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Any forward-looking statements in our releases include statements regarding the intent, belief or current expectations of Elbit Imaging Ltd. and our management about our business, financial condition, results of operations, and its relationship with its employees and the condition of our properties. Words such as "believe," "would," "expect," "intend," "estimate" and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors including, without limitation, the factors set forth in our filings with the Securities and Exchange Commission including, without limitation, Item 3.D of our annual report on Form 20-F for the fiscal year ended December 31, 2012, under the caption "Risk Factors." Any forward-looking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forward-looking statements do not purport to be predictions of future events or circumstances, and therefore, there can be no assurance that any forward-looking statement contained our releases will prove to be accurate. We undertake no obligation to update or revise any forward-looking statements.



For Further Information:

Company Contact:    

Shimon Yitzhaki    

Chairman of the Board of Directors    

Tel: +972-3-608-6048    

shimony@elbitimaging.com  

SOURCE Elbit Imaging Ltd.


Quelle: PR Newswire  

Bist du bei Elbit Imaging investiert? Habe mir dies vor ein paar Tagen auch überlegt, als die Preise zwischen 0.18 und 0.20 hin und her sprangen bei hohen Volumen. Doch mir war das Risiko zu hoch. Zudem kann ich diese Aktien nur über meine Tradingbank handeln lassen, sprich nur per Klick in Auftrag geben, jedoch zeitlich nicht 1:1.

Sollte die Bude wieder kommen, könnte man ein Vermögen machen, ansonsten war es dann ein Flop. Gestern ging es ja wie die Rakete nach oben. Bin mal gespannt, ob es wieder etwas runter kommt, das Risiko besteht ja immer noch. Sind sicher auch viele Short Posis einzudecken.  

Datum Erster Hoch Tief Schluss     Stücke Volumen
18.03.14 0,23 0,299 0,23  0,27 $ 10.206.342 2,68 M

..wenn ne Tickerlampe über'n Parkett platzt ..gehört der Konzern Dir

.                   ...mal nen fixen Gruss an alkotonic und buran hier ;-)  

http://www.ariva.de/news/...its-Extraordinary-General-Meeting-4962379 GrB  

Habe mir mal ein paar Stücke ins Depot gelegt. Denke mal das es zuerst aufwärts geht und hoffe, dass uns hier kein Reverse Splitting droht - weil davor und danach der Kurs immer in den Keller saust. Das ist das Risiko.  

Investment In InSightec Ltd.
23:00 13.04.14

PR Newswire

TEL AVIV, Israel, April 13, 2014

TEL AVIV, Israel, April 13, 2014 /PRNewswire/ -- Elbit Imaging Ltd. ("EI" or the "Company") (TASE, NASDAQ: EMITF) announced today that Elbit Medical Technologies Ltd. ("Elbit Medical") (TASE: EMTC-M), a subsidiary of the Company in which it holds approximately 86% of the voting power, announced that on March 25, 2014, InSightec Ltd. ("InSightec"), in which Elbit Medical holds approximately 48.2% of the share capital (approximately 42.3% on a fully diluted basis), has notified Elbit Medical that the Board of Directors of InSightec has approved the terms of a certain non-binding draft term sheet with a third-party investor (the "Investor"), which is not a current shareholder of InSightec, pertaining to an investment, pursuant to which the Investor shall invest in InSightec share capital. The proposed investment shall amount to few dozens of millions of US dollars, and will be based on a company valuation which is significantly higher than the company valuation set on the previous round of capital investment in InSightec; and on April 6, 2014, InSightec has notified Elbit Medical that the aforementioned non-binding term sheet was signed by it and the Investor.

It shall be noted that no definitive agreement has been signed to date and there is no certainty that the negotiation of such non-binding term sheet will lead to the conclusion of a definitive agreement or that a transaction will be completed. The execution of a definitive agreement is subject to certain conditions precedent, including but not limited to, the approval of the authorized corporate organs of each of Elbit Medical, other shareholders of InSightec and the Investor.

About Elbit Imaging Ltd.

Elbit Imaging Ltd. operates in the following principal fields of business: (i) Commercial and Entertainment Centers - Initiation, construction and sale of shopping and entertainment centers and other mixed-use real property projects, predominantly in the retail sector, located in Central and Eastern Europe and in India, primarily through its subsidiary Plaza Centers N.V. In certain circumstances and depending on market conditions, the Company operate and manage commercial and entertainment centers prior to their sale; (ii) Hotels - Hotel operation and management; (iii) Medical Industries - (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine; (iv) Residential Projects - Initiation, construction and sale of residential projects and other mixed-use real property projects, predominately residential, located primarily in India; and (v) Fashion Apparel - Distribution and marketing of fashion apparel and accessories in Israel.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Any forward-looking statements in our releases include statements regarding the intent, belief or current expectations of Elbit Imaging Ltd. and our management about our business, financial condition, results of operations, and its relationship with its employees and the condition of our properties. Words such as "believe," "would," "expect," "intend," "estimate" and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors including, without limitation, the factors set forth in our filings with the Securities and Exchange Commission including, without limitation, Item 3.D of our annual report on Form 20-F for the fiscal year ended December 31, 2012, under the caption "Risk Factors." Any forward-looking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forward-looking statements do not purport to be predictions of future events or circumstances, and therefore, there can be no assurance that any forward-looking statement contained our releases will prove to be accurate. We undertake no obligation to update or revise any forward-looking statements.

For Further Information:





Doron Moshe



Chief Financial Officer



Tel: +972-3-608-6025



doronm@elbitimaging.com  







Tal Shani



Corporate Secretary



Tel: +972-3-608-6056



tals@elbitimaging.com



SOURCE Elbit Imaging


Quelle: PR Newswire  

Elbit Imaging Announces The Results Of The Meeting Of The Holders Of The Company's Notes (series H) Approving Postponement Of The Creating And Registering Of The Collaterals Securing The Notes
00:15 14.04.14

PR Newswire

TEL AVIV, Israel, April 13, 2014

TEL AVIV, Israel, April 13, 2014 /PRNewswire/ -- Elbit Imaging Ltd. (the "Company") (TASE, NASDAQ: EMITF) announced today, further to the Company's announcement on February 10, 2014, the results of the meeting of the Holders of the Company's Notes (Series H) (the "Meeting") that voted on the postponement of the last date for creating and registering of the collaterals securing the notes in accordance with the terms of the plan of arrangement between the Company and its unsecured financial creditors (the "Arrangement"), until July 31, 2014.

At the Meeting, noteholders holding approximately 99.99% of the aggregate voting power participating in the Meeting voted in favor of the Resolution.

About Elbit Imaging Ltd.

Elbit Imaging Ltd. operates in the following principal fields of business: (i) Commercial and Entertainment Centers - Initiation, construction and sale of shopping and entertainment centers and other mixed-use real property projects, predominantly in the retail sector, located in Central and Eastern Europe and in India, primarily through its subsidiary Plaza Centers N.V. In certain circumstances and depending on market conditions, the Company operate and manage commercial and entertainment centers prior to their sale; (ii) Hotels - Hotel operation and management; (iii) Medical Industries - (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine; (iv) Residential Projects - Initiation, construction and sale of residential projects and other mixed-use real property projects, predominately residential, located primarily in India; and (v) Fashion Apparel - Distribution and marketing of fashion apparel and accessories in Israel.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Any forward-looking statements in our releases include statements regarding the intent, belief or current expectations of Elbit Imaging Ltd. and our management about our business, financial condition, results of operations, and its relationship with its employees and the condition of our properties. Words such as "believe," "would," "expect," "intend," "estimate" and similar expressionsare intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors including, without limitation, that the Tel-Aviv District Court may reject the Postponement, that challenges by third parties or other events outside the control of the Company could delay the implementation of the Arrangement and result in its termination, that  the Company will be unable to close the agreement with Bank Hapoalim, the risk that the Company will enter liquidation proceedings, and the factors set forth in our filings with the Securities and Exchange Commission including, without limitation, Item 3.D of our annual report on Form 20-F for the fiscal year ended December 31, 2012, under the caption "Risk Factors." Any forward-looking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forward-looking statements do not purport to be predictions of future events or circumstances, and therefore, there can be no assurance that any forward-looking statement contained our releases will prove to be accurate. We undertake no obligation to update or revise any forward-looking statements.

For Further Information:

Tal Shani



Corporate Secretary



Tel: +972-3-608-6056



tals@elbitimaging.com











SOURCE Elbit Imaging


Quelle: PR Newswire  

Hallo Buran,

wie schätzt Du die derzeitige Situation bei Elbit ein ?

Und wie hoch ist Dein Kursziel (realistisches) und innerhalb welches Zeitrahmen ?

Vielen Dank im Voraus für Deine Einschätzung.

Moneyplus